|
Volumn 137, Issue 9, 2018, Pages 886-888
|
Perspective from Sweden on the global impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines A "sprint" beyond Evidence in the United States
|
Author keywords
Antiyhypertensive agents; Blood pressure; Blood pressure determination; Guideline; Hypertension
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
BLOOD PRESSURE MEASUREMENT;
BLOOD PRESSURE MONITORING;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL PRACTICE;
DRUG EFFECT;
EVIDENCE BASED MEDICINE;
FOLLOW UP;
HEALTH IMPACT ASSESSMENT;
HUMAN;
HYPERTENSION;
MEDICAL SOCIETY;
PRACTICE GUIDELINE;
PREVALENCE;
PRIORITY JOURNAL;
REVIEW;
SWEDEN;
SYSTOLIC BLOOD PRESSURE;
CARDIOLOGY;
COMPARATIVE STUDY;
EVIDENCE BASED PRACTICE;
TRENDS;
UNITED STATES;
AMERICAN HEART ASSOCIATION;
ANTIHYPERTENSIVE AGENTS;
CARDIOLOGY;
EVIDENCE-BASED PRACTICE;
HUMANS;
HYPERTENSION;
PRACTICE GUIDELINES AS TOPIC;
SWEDEN;
UNITED STATES;
|
EID: 85047722273
PISSN: 00097322
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.118.033632 Document Type: Review |
Times cited : (20)
|
References (6)
|